Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Veliparib (ABT-888) with carboplatin and paclitaxel for advanced or metastatic non-squamous (current or former smokers) non-small cell lung cancer	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2017	View \| Download
Vedolizumab for treating active pouchitis	Vedolizumab (Entyvio; LDP-02; MLN0002)	Pouchitis	Gastroenterology	2022	View \| Download
Vanzacaftor / tezacaftor / deutivacaftor for the treatment of cystic fibrosis	Deutivacaftor , Tezacaftor (VX-661) , Vanzacaftor	Cystic fibrosis	Genetic Disorders , Respiratory System	2023	View \| Download
Vamorolone for treating Duchenne muscular dystrophy	Vamorolone (VBP15)	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2021	View \| Download
Valoctocogene Roxaparvovec for Severe Haemophilia A	Valoctocogene Roxaparvovec (BMN 270)	Haemophilia A	Haematology	2020	View \| Download
Vadadustat for treating anaemia in chronic kidney disease	Vadadustat (AKB-6548)	Anaemia	Haematology	2021	View \| Download
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children	Ustekinumab (Stelara; CNTO 1275; CNTO-1275)	Crohn's disease	Gastroenterology , Immunology	2023	View \| Download
Ustekinumab for Moderately to Severely Active Ulcerative Colitis	Ustekinumab (Stelara; CNTO 1275; CNTO-1275)	Ulcerative colitis	Gastroenterology	2018	View \| Download
Ustekinumab biosimilar for treating moderate to severe plaque psoriasis	Ustekinumab biosimilar (ONS3040; FYB202; CT-P43; BAT2206; DMB-3115; SB17; Bmab 1200; AVT04; ABP654)	Plaque psoriasis	Dermatology	2022	View \| Download
Ustekinumab biosimilar for Plaque psoriasis	Ustekinumab biosimilar (ONS3040; FYB202; CT-P43; BAT2206; DMB-3115; SB17; Bmab 1200; AVT04; ABP654)	Plaque psoriasis	Dermatology	2022	View \| Download